Clinical Model for Early Predictors of Necrotizing Enterocolitis in Neonates
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 450
- 试验地点
- 2
- 主要终点
- splanchnic tissue oxygenation in population at high risk for NEC
研究概览
简要总结
The goal of this project is to identify neonates who are predisposed to Necrotizing Enterocolitis (NEC). the investigators will determine the effectiveness of non-invasive measures as well as biochemical markers to identify neonates early in the disease process. Thus, the investigators aim to identify infants with NEC prior to the onset of symptoms to institute or test treatments in the long term to prevent the progression of the disease in these infants.
详细描述
The study will enroll premature, low birth weight infants in the Neonatal Intensive Care Units (NICU). Potential study subjects will be identified upon delivery, or transfer to the NICU, and notification by the neonatology service. Infants born at less than 30 weeks gestational age, birth weight less than or equal to 1500 grams will be eligible for enrollment in the study. The purpose of the study designed is to compare the splanchnic tissue oxygenation index and gut inflammatory biomarkers of patients with any stage of NEC with healthy controls. Since we will not be able to determine which patients will develop NEC a priori, we will anticipate enrolling up to 450 neonates to identify 15 neonates with NEC.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- — 至 7 Days（Child）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Infants born at ≤30 weeks gestational age and/or
- •Infants with a birth weight ≤1500 grams
排除标准
- •gestational age at birth greater than 30 weeks
- •obvious dysmorphic syndromes
- •any abdominal wall defect including omphalocele or gastroschisis
- •any known intestinal atresia
- •complex cardiac abnormalities
- •any known lethal chromosomal abnormalities
结局指标
主要结局
splanchnic tissue oxygenation in population at high risk for NEC
时间窗: 2026
splanchnic tissue oxygenation as a predictor of NEC
次要结局
未报告次要终点
研究者
Oluyinka Olutoye, MD, PhD
Principal Investigator
Nationwide Children's Hospital